![](/img/cover-not-exists.png)
Combination of the R263K and M184I/V Resistance Substitutions against Dolutegravir and Lamivudine Decreases HIV Replicative Capacity
Singhroy, Diane N., Wainberg, Mark A., Mesplède, ThibaultVolume:
59
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/aac.05181-14
Date:
May, 2015
File:
PDF, 1.57 MB
english, 2015